Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Primo Nutraceuticals Inc BUGVF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Primo Nutraceuticals Inc is engaged in the production, processing, retail and branding of cannabis and cannabis-related products. The company offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors.


GREY:BUGVF - Post by User

Primo Nutraceuticals Inc > PRESS RELEASE: Primo Signs Definitive Agreement
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(79)
•••
Post by Just33on Sep 24, 2020 9:20am
100 Views
Post# 31610382

PRESS RELEASE: Primo Signs Definitive Agreement

PRESS RELEASE: Primo Signs Definitive AgreementVANCOUVER, British Columbia, Sept. 24, 2020 (GLOBE NEWSWIRE) --PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("Primo" or the "Company") is pleased to announce that further to the Letter of Intent (the "LOI") with Duquette Consulting LLC ("Duquette Consulting“) referred to in the Company’s news release dated September 1, 2020 the Company has signed a Sales & Marketing Agreement to consummate the transaction.

https://www.globenewswire.com/news-release/2020/09/24/2098729/0/en/Primo-Nutraceuticals-Inc-and-Dan-Duquette-Former-MLB-Executive-Sign-Definitive-Agreement-to-Capitalize-on-Primo-Receiving-an-MDEL-License-from-Health-Canada-and-announces-Stock-Opt.html
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities